ARCA Discovery has found a way to position beta blockers-notably, bucindolol, which it has in-licensed--as heart failure drugs, using a molecular diagnostic to identify up front the patients who would have a good response and to eliminate those who'd have an adverse effect from the drug.
1200 17th Street
Suite 620
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Astellas will pay $130m up front for near-global rights to a Phase I/II antibody-drug conjugate that will add to its portfolio of CLDN.18.2-targeted drugs, including Vyloy.
The company has moved quickly to wind down operations after its anti-TIGIT pact with GSK collapsed.
Aurobindo is banking on launches of loss of exclusivity products and biosimilars to fuel sales in Europe as it awaits a US announcement on tariffs and predicts high single-digit growth overall during FY26 for now
Spero and partner GSK have Phase III non-inferiority data to support approval of tebipenem as the first oral antibiotic for complicated urinary tract infections.
Eye drug is already in Phase III trials elsewhere, with results due in Q3. Nicox could earn up to a further €24.5m in milestones and royalties from Kowa alliance.
Spero and partner GSK have Phase III non-inferiority data to support approval of tebipenem as the first oral antibiotic for complicated urinary tract infections.
CEO Matt Gline talked to Scrip in an interview about dealmaking and the road back to commercialization.
